Cargando…
Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series
The purpose of this study was to describe the surgical outcomes and safety of intracameral bevacizumab during trabeculectomy in eyes with neovascular glaucoma. Pilot study included four eyes (four patients) with refractory neovascular glaucoma submitted to fornix-based trabeculectomy with adjunctive...
Autores principales: | de Moraes, Carlos Gustavo Vasconcelos, Facio, Antonio Carlos, Costa, José Humberto, Malta, Roberto Freire Santiago |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802500/ https://www.ncbi.nlm.nih.gov/pubmed/20072647 http://dx.doi.org/10.1007/s12177-009-9020-z |
Ejemplares similares
-
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey, Hatem M, et al.
Publicado: (2011) -
Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
por: Ha, Jun Young, et al.
Publicado: (2017) -
Concentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
por: Lim, Tae Hoon, et al.
Publicado: (2009) -
The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
por: Alagöz, Neşe, et al.
Publicado: (2016) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014)